Skip to content
Therapy But Better – Lifestyle
Author:
Castle Biosciences, Inc.
New Data at DDW 2026 Show TissueCypher® Testing Improves Risk Stratification and Drives Risk-Aligned Management in Barrett’s Esophagus
May 5, 2026
Castle Biosciences Supports Nationwide Patient Advocacy and Screening Initiatives to Celebrate Skin Cancer Awareness Month
May 5, 2026
Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma’s Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS
April 21, 2026
Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026
April 15, 2026
←
Previous Page
1
2
3